DuPont To Sell Kevlar, Nomex Business To TJC-Backed Arclin In $1.8 Billion Deal

The transaction is expected to close in early 2026 pending approvals, with DuPont receiving $1.2 billion in cash.

DuPont (DD) announced on Friday that it has agreed to sell its Aramids unit, which makes Kevlar and Nomex, to TJC (TJC)-backed Arclin in a $1.8 billion deal.

The transaction, backed by fully committed financing, is expected to close in the first quarter of 2026 pending regulatory approval. At closing, DuPont will receive approximately $1.2 billion in pre-tax cash proceeds, a $300 million note receivable, and a non-controlling equity stake in the new Arclin, valued at roughly $325 million, or 17.5%.

Get updates to this developing story directly on Stocktwits.<

For updates and corrections, email newsroom[at]stocktwits[dot]com.<